Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Corcept Therapeutics Return on Tangible Equity 2010-2025 | CORT

Current and historical return on tangible equity values for Corcept Therapeutics (CORT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
Corcept Therapeutics Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.13B $0.68B 20.32%
2024-12-31 $0.14B $0.68B 22.74%
2024-09-30 $0.14B $0.64B 24.63%
2024-06-30 $0.13B $0.60B 23.66%
2024-03-31 $0.12B $0.55B 24.14%
2023-12-31 $0.11B $0.51B 21.86%
2023-09-30 $0.09B $0.46B 18.79%
2023-06-30 $0.09B $0.42B 19.51%
2023-03-31 $0.09B $0.53B 19.31%
2022-12-31 $0.10B $0.50B 22.14%
2022-09-30 $0.12B $0.47B 27.55%
2022-06-30 $0.11B $0.44B 25.37%
2022-03-31 $0.11B $0.41B 24.26%
2021-12-31 $0.11B $0.38B 22.97%
2021-09-30 $0.11B $0.54B 20.22%
2021-06-30 $0.10B $0.52B 19.15%
2021-03-31 $0.10B $0.51B 20.02%
2020-12-31 $0.11B $0.52B 22.60%
2020-09-30 $0.11B $0.49B 25.29%
2020-06-30 $0.11B $0.45B 28.83%
2020-03-31 $0.11B $0.41B 29.75%
2019-12-31 $0.09B $0.37B 28.86%
2019-09-30 $0.09B $0.33B 28.81%
2019-06-30 $0.08B $0.30B 27.86%
2019-03-31 $0.08B $0.29B 28.52%
2018-12-31 $0.08B $0.28B 30.15%
2018-09-30 $0.15B $0.26B 66.37%
2018-06-30 $0.15B $0.24B 79.89%
2018-03-31 $0.14B $0.22B 101.79%
2017-12-31 $0.13B $0.19B 131.30%
2017-09-30 $0.04B $0.09B 59.26%
2017-06-30 $0.03B $0.07B 53.19%
2017-03-31 $0.01B $0.05B 35.14%
2016-12-31 $0.01B $0.04B 30.51%
2016-09-30 $0.01B $0.03B 21.05%
2016-06-30 $0.00B $0.03B 5.19%
2016-03-31 $0.00B $0.02B -12.70%
2015-12-31 $-0.01B $0.02B -51.85%
2015-09-30 $-0.01B $0.01B -145.45%
2015-06-30 $-0.02B $0.01B -357.89%
2015-03-31 $-0.02B $0.01B -920.00%
2014-12-31 $-0.03B $0.00B -1600.00%
2014-09-30 $-0.04B $0.00B -487.50%
2014-06-30 $-0.04B $0.00B -275.00%
2014-03-31 $-0.05B $0.01B -190.10%
2013-12-31 $-0.05B $0.02B -128.67%
2013-09-30 $-0.05B $0.03B -100.00%
2013-06-30 $-0.04B $0.04B -76.44%
2013-03-31 $-0.04B $0.05B -71.56%
2012-12-31 $-0.04B $0.06B -73.79%
2012-09-30 $-0.04B $0.07B -82.68%
2012-06-30 $-0.04B $0.03B -92.72%
2012-03-31 $-0.04B $0.04B -86.23%
2011-12-31 $-0.03B $0.04B -69.19%
2011-09-30 $-0.03B $0.04B -67.84%
2011-06-30 $-0.03B $0.05B -77.92%
2011-03-31 $-0.03B $0.06B -78.26%
2010-12-31 $-0.03B $0.02B -106.12%
2010-09-30 $-0.02B $0.03B -96.97%
2010-06-30 $-0.02B $0.03B -108.64%
2010-03-31 $-0.02B $0.02B -137.70%
2009-12-31 $-0.02B $0.02B -129.03%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.587B $0.675B
Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone), is approved for the once-daily oral treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, suffering from type II diabetes or glucose intolerance and who have failed surgery or are not suitable for surgery.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.420B 26.32
Zoetis (ZTS) United States $67.834B 24.61
Takeda Pharmaceutical (TAK) Japan $47.092B 9.61
Daiichi Sankyo, - (DSNKY) Japan $46.241B 23.70
BeOne Medicines - (ONC) Switzerland $33.942B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.788B 0.00
Summit Therapeutics (SMMT) United States $19.648B 0.00
Merck (MKKGY) Germany $16.685B 10.85
Shionogi (SGIOY) Japan $15.142B 15.17
United Therapeutics (UTHR) United States $14.076B 12.18
Neurocrine Biosciences (NBIX) United States $13.024B 38.85
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.601B 0.00
Madrigal Pharmaceuticals (MDGL) United States $8.246B 0.00
Grifols, S.A (GRFS) Spain $7.384B 0.00
Ionis Pharmaceuticals (IONS) United States $6.830B 0.00
Stevanato Group S.p.A (STVN) Italy $6.714B 39.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.111B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.949B 14.02
NewAmsterdam Pharma (NAMS) Netherlands $2.826B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.796B 0.00
Hypermarcas (HYPMY) Brazil $2.559B 19.24
Catalyst Pharmaceuticals (CPRX) United States $2.456B 8.23
Centessa Pharmaceuticals (CNTA) United Kingdom $2.365B 0.00
Ocular Therapeutix (OCUL) United States $2.201B 0.00
Dyne Therapeutics (DYN) United States $1.778B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.774B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.591B 23.71
Guardian Pharmacy Services (GRDN) United States $1.512B 0.00
Harrow (HROW) United States $1.480B 0.00
ARS Pharmaceuticals (SPRY) United States $1.430B 0.00
Ardelyx (ARDX) United States $1.407B 0.00
Evotec AG (EVO) Germany $1.357B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.311B 0.00
Xeris Biopharma Holdings (XERS) United States $1.179B 0.00
Enliven Therapeutics (ELVN) United States $1.171B 0.00
Collegium Pharmaceutical (COLL) United States $1.171B 6.40
Cronos Group (CRON) Canada $0.965B 0.00
Akebia Therapeutics (AKBA) United States $0.872B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.750B 0.00
ProKidney (PROK) United States $0.708B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.680B 7.00
Theravance Biopharma (TBPH) United States $0.652B 53.92
KalVista Pharmaceuticals (KALV) United States $0.647B 0.00
Siga Technologies (SIGA) United States $0.614B 7.59
Bioventus (BVS) United States $0.607B 14.68
Organogenesis (ORGO) United States $0.596B 0.00
Relay Therapeutics (RLAY) United States $0.584B 0.00
Tourmaline Bio (TRML) United States $0.575B 0.00
Elite Pharmaceuticals (ELTP) United States $0.567B 0.00
Oruka Therapeutics (ORKA) United States $0.562B 0.00
USANA Health Sciences (USNA) United States $0.558B 11.43
Xencor (XNCR) United States $0.546B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.522B 0.00
Savara (SVRA) United States $0.520B 0.00
Nektar Therapeutics (NKTR) United States $0.508B 0.00
Zevra Therapeutics (ZVRA) United States $0.500B 0.00
Esperion Therapeutics (ESPR) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.410B 0.00
Nanobiotix S.A (NBTX) France $0.393B 0.00
Larimar Therapeutics (LRMR) United States $0.353B 0.00
4D Molecular Therapeutics (FDMT) United States $0.332B 0.00
Altimmune (ALT) United States $0.325B 0.00
Aldeyra Therapeutics (ALDX) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.292B 19.06
AleAnna (ANNA) United States $0.283B 0.00
OmniAb (OABI) United States $0.244B 0.00
Galectin Therapeutics (GALT) United States $0.238B 0.00
Heron Therapeutics (HRTX) United States $0.207B 0.00
Lyell Immunopharma (LYEL) United States $0.207B 0.00
MediWound (MDWD) Israel $0.201B 0.00
Korro Bio (KRRO) United States $0.187B 0.00
China SXT Pharmaceuticals (SXTC) China $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.183B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.173B 26.75
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Profound Medical (PROF) Canada $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.118B 0.00
Avalo Therapeutics (AVTX) United States $0.118B 0.00
Cassava Sciences (SAVA) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.112B 0.00
Liminatus Pharma (LIMN) United States $0.107B 0.00
Dominari Holdings (DOMH) United States $0.096B 0.00
Surrozen (SRZN) United States $0.093B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.38
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.063B 0.00
DURECT (DRRX) United States $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Wellgistics Health (WGRX) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.18
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Enlivex Therapeutics (ENLV) Israel $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
FibroGen (FGEN) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Ainos (AIMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.02
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.02
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00